Strategic Collaboration Exactis Innovation partners with leading genomic data platforms like Sophia Genetics to enhance multimodal real-world data capabilities for cancer research in Canada, indicating a sales opportunity for data integration, co-marketing, and cross-sell of RWE services.

Scale & Access As a pan-Canadian network of oncology centers with a focus on real-world evidence, Exactis offers a gateway to multi-site data and patient cohorts, presenting a compelling value proposition for vendors seeking broad clinical datasets or site-level analytics partnerships.

SMB Focus With a small team and annual revenue under one million, Exactis is likely open to scalable, low-friction deals, channel partnerships, and modular service offerings that align with cost-conscious budgeting while expanding research capabilities.

Clinical Innovation Historically engaged in proteomics, immunotherapy guidance, and post-market drug evaluation, Exactis targets advanced precision medicine use cases, offering upsell potential in proteomic assays, biomarker discovery, and real-world oncology analytics.

Public-Private Value As a non-profit aligned with CADTH PMDE programs, Exactis seeks outcomes-focused partnerships that demonstrate real patient impact and policy-relevant insights, creating opportunities for demonstrations, case studies, and funded or co-sponsored research engagements.